Showing results (61-70 of 279) with videos related to

Sort By:
Pageof 28
Haematologica|January 26, 2013
NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemiaObul R Bandapalli, Martin Zimmermann, Corinne Kox, et al.
Blood|June 1, 2007
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathwayBeat C Bornhauser, Laura Bonapace, Dan Lindholm, et al.
Haematologica|November 21, 2007
Incidence and outcome of TCF3-PBX1-positive acute lymphoblastic leukemia in Austrian childrenLeo Kager, Thomas Lion, Andishe Attarbaschi, et al.
Epigenomics|January 16, 2018
NGS-based methylation profiling differentiates TCF3-HLF and TCF3-PBX1 positive B-cell acute lymphoblastic leukemiaPriyadarshini Kachroo, Silke Szymczak, Femke-Anouska Heinsen, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 16, 2013
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphomaAnna Czajczynska, Andreas Günther, Roland Repp, et al.
Pediatric Hematology and Oncology|April 25, 2007
Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-upPaul Krappmann, Marios Paulides, Wolfgang Stöhr, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 14, 2024
High Parathyroid Hormone Rather than Low Vitamin D Is Associated with Reduced Event-Free Survival in Childhood CancerCorinna Grasemann, Jakob Höppner, Wolfgang Högler, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Minimal residual disease after induction is the strongest predictor of prognosis in intermediate risk relapsed acute lymphoblastic leukaemia - long-term results of trial ALL-REZ BFM P95/96Cornelia Eckert, Arend von Stackelberg, Karl Seeger, et al.
British Journal of Haematology|July 21, 2018
Expression of CD56 defines a distinct subgroup in childhood T-ALL with inferior outcome. Results of the ALL-BFM 2000 trialStephan Fuhrmann, Richard Schabath, Anja Möricke, et al.
Haematologica|January 25, 2012
Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemiaMelchior Lauten, Anja Möricke, Rita Beier, et al.
Pageof 28